Deslanoside
Back to searchMolecule Structure
Scientific Name
Deslanoside
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01078
http://www.drugbank.ca/drugs/DB01078
Brand Name(s)
Cedilanid-d
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium/potassium-transporting ATPase | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095186 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL125311 |
| Human Metabolome Database | HMDB0015211 |
| DrugBank | DB01078 |
| PubChem | 28620 |
| NMRShiftDB | 60064373 |
| Nikkaji | J4.081I |
| EPA CompTox Dashboard | DTXSID1022897 |
| DrugCentral | 813 |
| Metabolights | MTBLC31468 |
| ChemicalBook | CB6683081 |
| Guide to Pharmacology | 6806 |
| rxnorm | DESLANOSIDE |
| ChEBI | 31468 |
| ZINC | ZINC000253668332 |
